Moderna logo

Latest headlines

Moderna News

The latest Moderna (MRNA) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these MRNA headlines next to the live Moderna Fear and Greed Index.

Latest Moderna Headlines54

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

zacks.com · Jul 31, 2026

Moderna, Inc. (MRNA) Q2 2026 Earnings Call Transcript

seekingalpha.com · Jul 31, 2026

Moderna Q2: Weak Revenue, Strong Pipeline - Here's What Matters Now

seekingalpha.com · Jul 31, 2026

Moderna Q2 Earnings Call Highlights

marketbeat.com · Jul 31, 2026

Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates

zacks.com · Jul 31, 2026

Optimistic Tech Earnings Lift Stock Futures

schaeffersresearch.com · Jul 31, 2026

Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations

wsj.com · Jul 31, 2026

Breakfast News: AMZN Has Proof, Apple Has Problems

fool.com · Jul 31, 2026

Is Moderna Inc (MRNA) Overvalued After Q2 Earnings Report? EPS of -$1.97 Misses Estimate, Revenue of $145 Million Slightly Beats

gurufocus.com · Jul 31, 2026

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

barrons.com · Jul 31, 2026

Moderna misses quarterly revenue estimates on COVID vaccine weakness

reuters.com · Jul 31, 2026

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

accessnewswire.com · Jul 31, 2026

Moderna Q2 Earnings Loom: Buy or Sell the Stock Ahead of Results?

zacks.com · Jul 29, 2026

Moderna (MRNA) Laps the Stock Market: Here's Why

zacks.com · Jul 27, 2026

After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy?

fool.com · Jul 27, 2026

Moderna: A Stock to Watch or a Risky Bet?

fool.com · Jul 24, 2026

Will Moderna (MRNA) Report Negative Earnings Next Week? What You Should Know

zacks.com · Jul 24, 2026

Should You Buy Moderna Stock Hand Over Fist Before Aug. 5?

fool.com · Jul 21, 2026

IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?

fool.com · Jul 21, 2026

Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights

zacks.com · Jul 20, 2026

Moderna Is Up 109% in 2026. Jim Cramer Just Called It 'Finally Investable Again.

fool.com · Jul 20, 2026

MRNA Advances Cancer Pipeline With New Immunotherapy Study

zacks.com · Jul 17, 2026

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

accessnewswire.com · Jul 16, 2026

Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies

proactiveinvestors.com · Jul 14, 2026

Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies

proactiveinvestors.com · Jul 14, 2026

Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note

zacks.com · Jul 13, 2026

Arbutus Biopharma: Moderna Validates My IP Bull Case

seekingalpha.com · Jul 13, 2026

Moderna wins EU contract for RSV vaccine supply

reuters.com · Jul 9, 2026

Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026

accessnewswire.com · Jul 9, 2026

Moderna Appoints Michael McDonnell to Board of Directors

accessnewswire.com · Jul 8, 2026

Moderna Stock Is Soaring. Is It Too Late to Buy?

fool.com · Jul 7, 2026

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

zacks.com · Jul 6, 2026

These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More

fool.com · Jul 6, 2026

2 More Stocks to Buy for the AI Convergence

investorplace.com · Jul 5, 2026

Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%.

fool.com · Jul 3, 2026

MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?

zacks.com · Jul 3, 2026

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

fool.com · Jul 3, 2026

Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?

fool.com · Jul 3, 2026

Moderna stock jumps as pipeline progress and flu shot data lift sentiment

invezz.com · Jul 2, 2026

Short Squeeze Alert—Moderna Stock Surges on New Strategy

marketbeat.com · Jul 1, 2026

Is Moderna Stock a No-Brainer Buy After a Key FDA Win?

fool.com · Jun 30, 2026

MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines

zacks.com · Jun 29, 2026

Stock Of The Day: Will The Moderna Rally Continue?

benzinga.com · Jun 29, 2026

Moderna stock soars as cancer pipeline and CAR-T push ignite optimism

invezz.com · Jun 26, 2026

Why Moderna Stock Is Soaring and Leading the S&P 500 Today

barrons.com · Jun 26, 2026

From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak

feeds.newsfilecorp.com · Jun 26, 2026

This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst

fool.com · Jun 26, 2026

Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript

seekingalpha.com · Jun 25, 2026

Moderna Science Day Highlights Expanding Potential of mRNA Platform

accessnewswire.com · Jun 25, 2026

Moderna (MRNA) Rises As Market Takes a Dip: Key Facts

zacks.com · Jun 23, 2026

Major Indexes Continue Lower as Chip Selloff Drags Nasdaq

schaeffersresearch.com · Jun 23, 2026

Should You Buy Moderna Before Aug. 5?

fool.com · Jun 22, 2026

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

fool.com · Jun 20, 2026

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing

zacks.com · Jun 19, 2026

Why Is Moderna Up or Down Today?

When Moderna (MRNA) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a MRNA move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Moderna is up or down today.

How Moderna News Affects the Price

News does not move the Moderna (MRNA) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Moderna Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Moderna trading volume. That is the chain to watch: headline, sentiment, volume, then the MRNA price.

Trade the Moderna News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Moderna trading volume spike on a big story, check the Moderna price history for context, follow the live MRNA price, see the Moderna price prediction, and read the Moderna Fear and Greed Index for mood.

How do you feel about Moderna?

1D

Frequently asked questions

Why is Moderna up or down today?
Moderna (MRNA) moves on news, and the headlines above are the fastest way to see what is driving MRNA today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Moderna Fear and Greed Index and MRNA trading volume.
What is the latest Moderna news?
The newest Moderna (MRNA) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent MRNA news cycle in one place.
Where does Moderna news come from?
We aggregate Moderna (MRNA) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.
How often is Moderna news updated?
Continuously. The Moderna (MRNA) feed refreshes as new stories are published, so the headlines at the top are the freshest available.
How does Moderna news relate to its Fear and Greed Index?
News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Moderna Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.